SITAGLIPTIN VERSUS PLACEBO IN THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CONTROLLED TRIAL

被引：5

作者：

Cui, J. Y. ^{[1
]}

Philo, L. ^{[2
]}

Nguyen, P. ^{[1
]}

Hofflich, H. ^{[3
]}

Hernandez, C. ^{[1
]}

Bettencourt, R. ^{[4
]}

Richards, L. ^{[1
]}

Salotti, J. ^{[1
]}

Bhatt, A. ^{[1
]}

Hooker, J. ^{[5
]}

Haufe, W. ^{[5
]}

Hooker, C. ^{[1
]}

Brenner, D. A. ^{[6
]}

Sirlin, C. B. ^{[5
]}

Loomba, R. ^{[1
,4
,6
,7
]}

机构：

[1] UC San Diego Sch Med, Dept Med, NAFLD Res Ctr, La Jolla, CA USA

[2] Naval Med Ctr, San Diego, CA USA

[3] UC San Diego Sch Med, Div Gen Internal Med, La Jolla, CA USA

[4] UC San Diego Sch Med, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA USA

[5] UC San Diego Sch Med, Dept Radiol, Liver Imaging Grp, La Jolla, CA USA

[6] UC San Diego Sch Med, Dept Med, Div Gastroenterol, La Jolla, CA USA

[7] San Diego Integrated NAFLD Consortium, San Diego, CA USA

来源：

JOURNAL OF HEPATOLOGY | 2016年 / 64卷

关键词：

D O I：

10.1016/S0168-8278(16)00137-9

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PS112

引用

页码：S192 / S193

页数：2

共 50 条

[21] Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial
Wojciech Janczyk
Piotr Socha
Dariusz Lebensztejn
Aldona Wierzbicka
Artur Mazur
Joanna Neuhoff-Murawska
Pawel Matusik
BMC Pediatrics, 13
[22] Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial
Janczyk, Wojciech
Socha, Piotr
Lebensztejn, Dariusz
Wierzbicka, Aldona
Mazur, Artur
Neuhoff-Murawska, Joanna
Matusik, Pawel
BMC PEDIATRICS, 2013, 13
[23] A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes
Doustmohammadian, Azam
Nezhadisalami, Ahmad
Safarnezhad Tameshke, Fahimeh
Motamed, Nima
Maadi, Mansooreh
Farahmand, Mohammad
Sohrabi, Masoudreza
Clark, Cain C. T.
Ajdarkosh, Hossein
Faraji, Amir Hossein
Nikkhah, Mehdi
Sobhrakhshankhah, Elham
Ebrahimi, Ramin
Zamani, Farhad
FRONTIERS IN MEDICINE, 2022, 9
[24] Data from a randomized and controlled trial of L-Carnitine prescription for the treatment for Non-Alcoholic Fatty Liver Disease
Somi, Mohamad Hosein
Fatahi, Ebrahim
Panahi, Jafar
Havasian, Mohamad Reza
Judaki, Arezo
BIOINFORMATION, 2014, 10 (09) : 575 - 579
[25] Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial
Lukenda Zanko, Vesna
Domislovic, Viktor
Trkulja, Vladimir
Krznaric-Zrnic, Irena
Turk-Wensveen, Tamara
Krznaric, Zeljko
Filipec Kanizaj, Tajana
Radic-Kristo, Delfa
Bilic-Zulle, Lidija
Orlic, Lidija
Dinjar-Kujundzic, Petra
Poropat, Goran
Stimac, Davor
Hauser, Goran
Mikolasevic, Ivana
DIABETES OBESITY & METABOLISM, 2020, 22 (11): : 2097 - 2106
[26] Dynamic Change of Focal Fatty Sparing in Non-Alcoholic Fatty Liver Disease after Treatment with Sitagliptin
Hoffmanova, I.
Skrha, P.
Sedo, A.
Andel, M.
ULTRASOUND INTERNATIONAL OPEN, 2016, 2 (03) : E98 - E99
[27] RANDOMISED, PLACEBO-CONTROLLED CLINICAL TRIAL: LONG-TERM RESVERATROL TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASE
Heeboll, S.
Hamilton-Dutoit, S.
Hellberg, Y. K.
Stodkilde-Jorgensen, H.
Jessen, N.
Pedersen, S. B.
Gronbaek, H.
JOURNAL OF HEPATOLOGY, 2015, 62 : S739 - S739
[28] Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver disease
Heeboll, Sara
Kreuzfeldt, Martin
Hamilton-Dutoit, Stephen
Poulsen, Marianne Kjaer
Stodkilde-Jorgensen, Hans
Moller, Holger Jon
Jessen, Niels
Thorsen, Kasper
Hellberg, Ylva Kristina
Pedersen, Steen Bonlokke
Gronbaek, Henning
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (04) : 456 - 463
[29] Treatment of Non-Alcoholic Fatty Liver Disease
Dyson, Jessica
Day, Chris
DIGESTIVE DISEASES, 2014, 32 (05) : 597 - 604
[30] Treatment of Non-Alcoholic Fatty Liver Disease
Scherer, Antonia
Dufour, Jean-Francois
DIGESTIVE DISEASES, 2016, 34 : 27 - 31

← 1 2 3 4 5 →